[1]
İlker Selçuk, “Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy”, Gynecol Obstet Reprod Med, vol. 21, no. 1, pp. 36–40, Apr. 2015.